PTGIR
Prostacyclin receptor
Also known as: IP, PI2R_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P43119
- Gene
- PTGIR
- Ensembl
- ENSG00000160013
- Chromosome
- 19
- Canonical length
- 386 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
The protein encoded by this gene is a member of the G-protein coupled receptor family 1 and has been shown to be a receptor for prostacyclin. Prostacyclin, the major product of cyclooxygenase in macrovascular endothelium, elicits a potent vasodilation and inhibition of platelet aggregation through binding to this receptor. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
386 residues, UniProt reviewed canonical sequence.
>P43119|PTGIR
1 MADSCRNLTY VRGSVGPATS TLMFVAGVVG NGLALGILSA RRPARPSAFA VLVTGLAATD
61 LLGTSFLSPA VFVAYARNSS LLGLARGGPA LCDAFAFAMT FFGLASMLIL FAMAVERCLA
121 LSHPYLYAQL DGPRCARLAL PAIYAFCVLF CALPLLGLGQ HQQYCPGSWC FLRMRWAQPG
181 GAAFSLAYAG LVALLVAAIF LCNGSVTLSL CRMYRQQKRH QGSLGPRPRT GEDEVDHLIL
241 LALMTVVMAV CSLPLTIRCF TQAVAPDSSS EMGDLLAFRF YAFNPILDPW VFILFRKAVF
301 QRLKLWVCCL CLGPAHGDSQ TPLSQLASGR RDPRAPSAPV GKEGSCVPLS AWGEGQVEPL
361 PPTQQSSGSA VGTSSKAEAS VACSLCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTGIR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 73 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 73 nTPM
- lung: 55 nTPM
- heart muscle: 27 nTPM
- thyroid gland: 17 nTPM
- kidney: 16 nTPM
- adipose tissue: 13 nTPM
Single-cell type
- platelets: 312 nCPM
- cdc: 75 nCPM
- vascular smooth muscle cells: 63 nCPM
- hepatic stellate cells: 45 nCPM
- pericytes: 41 nCPM
- megakaryocytes: 31 nCPM
Immune cell
- intermediate monocyte: 65 nTPM
- non-classical monocyte: 39 nTPM
- classical monocyte: 28 nTPM
- myeloid DC: 21 nTPM
- total PBMC: 18 nTPM
- T-reg: 3.9 nTPM
Brain region
- cerebral cortex: 1.3 nTPM
- medulla oblongata: 0.9 nTPM
- spinal cord: 0.9 nTPM
- hippocampal formation: 0.8 nTPM
- midbrain: 0.6 nTPM
- pons: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.61
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.39
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- cell-cell signaling
- G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
- inflammatory response
- negative regulation of platelet-derived growth factor receptor signaling pathway
- negative regulation of smooth muscle cell proliferation
- positive regulation of cytosolic calcium ion concentration
- response to lipopolysaccharide
Molecular functions
- guanyl-nucleotide exchange factor activity
- prostacyclin receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- G protein-coupled receptor, rhodopsin-like
- Prostanoid receptor
- GPCR, rhodopsin-like, 7TM
- 7 transmembrane receptor (rhodopsin family)
- Prostacyclin (prostanoid IP) receptor
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTGIR as an antibody target. Whether an autoantibody or antibody against PTGIR could matter depends on whether native PTGIR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTGIR is annotated at the cell surface, where native PTGIR is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PTGIR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...